Craft

Actylis

Stock Price

$0.1

2019-10-01

Market Capitalization

$4.1 M

2019-04-02

Revenue

$711.4 M

FY, 2018

Actylis Summary

Company Summary

Overview
Aceto Corporation sources, markets, sells, and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products, and specialty chemicals. The Company's Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements, including vitamins, amino acids, iron compounds, and bio chemicals used in pharmaceutical and nutritional preparations. This segment is also involved in developing and marketing generic pharmaceutical products. The Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates to various generic drug companies. The Performance Chemicals segment provides specialty chemicals, dye and pigment intermediates, and organic intermediates. This segment also offers agricultural protection products comprising herbicides, fungicides, and insecticides.
Type
Public
Status
Active
Founded
1947
HQ
Port Washington, NY, US | view all locations
Website
http://www.aceto.com/
Cybersecurity rating
Sectors

Key People

  • Gilles Cottier

    Gilles Cottier, Chief Executive Officer

    LocationsView all

    12 locations detected

    • Port Washington, NY HQ

      United States

      4 Tri Harbor Ct

    • Shang Hai Shi

      China

      Bei Jing Xi Lu, 久光 Jing An Qu

    • Lyon, Auvergne-Rhône-Alpes

      France

      3 Pl. Giovanni da Verrazzano

    • Paris, Île-de-France

      France

      43 Avenue Marceau

    • Düsseldorf, NRW

      Germany

      Hansaallee 159

    • Hamburg, HH

      Germany

      Hans-Henny-Jahnn-Weg 11/51

    and 6 others

    Actylis Financials

    Summary Financials

    Revenue (Q2, 2019)
    $163.6M
    Gross profit (Q2, 2019)
    $24.0M
    Net income (Q2, 2019)
    ($22.4M)
    Cash (Q2, 2019)
    $41.8M
    EBIT (Q2, 2019)
    ($15.1M)
    Enterprise value
    $279.5M

    Footer menu